This platform technology can provide a safer, more reliable way for patients to receive haemodialysis or bypass arterial blockages. Worldwide, these unmet clinical needs represent a £4.2 billion yearly available market
Enables safe needle crossing and guidewire placement across vessels
Dialysis patients
world wide
Surgical AVF
creations per year
patients globally
amputations p.a.
in the US and UK